Genome Biologics Overview

  • Founded
  • 2016
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $61.6K
Latest Deal Amount
  • Investors
  • 2

Genome Biologics General Information


Developer of a drug-disease matching platform designed to facilitate efficient and ethical drug development and positioning. The company's platform leverage the power of AI-based machine learning with a transformative single cell in vitro and in vivo transgenesis to identify new compounds or to repurpose known compounds for the treatment of cardiovascular and cardiometabolic and cancer, enabling medical researchers to reduce the cost, time, and ethical burden of preclinical research.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Technology Systems
Primary Office
  • Danziger Weg 17
  • 61476 Kronberg
  • Germany
+49 069 000000000

Genome Biologics Timeline

Financing RoundFinancing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Genome Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 09-Apr-2018 $61.6K Completed Startup
1. Accelerator/Incubator 23-Mar-2018 Completed Startup
To view Genome Biologics’s complete valuation and funding history, request access »

Genome Biologics Patents

Genome Biologics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10851388-B2 Tissue selective transgene expression Active 11-Nov-2015 000000000
US-20180334686-A1 Tissue selective transgene expression Granted 11-Nov-2015 000000000
EP-3374510-A1 Tissue selective transgene expression Pending 11-Nov-2015 C12N15/86

Genome Biologics Executive Team (3)

Name Title Board Seat Contact Info
Jonathan Ward Co-Founder & Chief Executive Officer
Maria Duda Ph.D Chief Operating Officer
Jaya Krishnan Ph.D Co-Founder & Chief Technology Officer
To view Genome Biologics’s complete executive team members history, request access »

Genome Biologics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizon 2020 Government 000 0000 000000 0
Johnson & Johnson Innovation - JLABS Accelerator/Incubator 000 0000 000000 0
To view Genome Biologics’s complete investors history, request access »